Zurich, 03rd June 2025 – The global market for transabdominal retrieval kits is projected to grow from USD 470 million in 2024 to USD 910 million by 2031, achieving a compound annual growth rate of 9.7%, according to Clearview Market Insights (CVMI).
“As ART cycles increase globally and fertility preservation becomes part of standard oncology care, transabdominal retrieval kits are evolving to meet safety, efficiency, and traceability needs,” said Dr. Lina Ostergaard, Senior Analyst at CVMI.
For more information or to download the full report, visit: https://clearviewmarketinsights.com/report-details/transabdominal-retrieval-kits-market/
Market Drivers
- Global infertility rates – Affecting 15 % of couples, driving the number of IVF retrievals.
- Rise in fertility preservation – Oncofertility programs and elective egg freezing boost use of single-use aspiration kits.
- ART access & tourism – Fertility care is expanding across geographies due to public-private partnerships and patient mobility.
- Innovation in retrieval tools – Needles with ultrasound-visible tips and low-volume tubing improve success and reduce trauma.
Competitive Landscape
Vitrolife leads the market with a 21% share, offering ultrasound-guided aspiration needles and customizable retrieval kits. Cook Medical (18%) leverages its global distribution and Asia-Pacific logistics. Rocket Medical’s NHS partnership strengthens its footprint in public systems. CooperSurgical and other OEMs continue to innovate in fluid dynamics and aspiration ergonomics.
Segmentation Highlight
By Product Type (2024 Share)
- Aspiration Needles – 38 %
- Tubing & Collection Vials – XX %
- Ultrasound-Guided Kits – XX %
- Flush Sets & Media – XX %
By End User (2024 Share)
- Private IVF Clinics – 41 %
- Hospital Fertility Units – XX %
- Cancer Centers – XX %
- Academic ART Labs – XX %
Private IVF centers remain the largest end users, while cancer centers and public hospitals are experiencing the fastest growth due to oncofertility adoption and policy shifts. Ultrasound-guided kits are gaining market share, projected to surpass 30% by 2028.
Regional Trends
- North America (XX %) – Strong ART demand and growing egg preservation post-cancer treatment.
- Europe (XX %) – State-covered IVF and oocyte donation programs support retrieval kit demand.
- Asia-Pacific (24 %) – Fastest CAGR 12.3 %; India and Thailand lead IVF procedure growth.
- LATAM & MEA (XX % combined) – IVF access expanding through fertility tourism and regional investment.
Innovation & Future Outlook
- Preloaded kits reduce set-up time in high-volume clinics.
- Echogenic tip design improves accuracy in challenging anatomy.
- Traceable disposables integrate with digital IVF lab platforms.
- Combined aspiration–flush kits may become standard by 2028.
“Retrieval kits are no longer basic consumables—they’re precision tools influencing outcomes,” said Dr. Keisha Tan, IVF Director at ReproCare Singapore.
2031 Forecast Milestones
- 2026 – Global ART cycles exceed 6 million/year.
- 2027 – Flush-integrated aspiration needles adopted in 40 % of IVF labs.
- 2028 – Universal IVF consumable barcoding standardised.
- 2029 – Custom kits for fibroid or retroverted uteruses gain wide adoption.
- 2030 – Low-cost retrieval systems enter public hospitals in 25+ LMICs.
- 2031 – 75 % of ART retrievals use fully traceable, preassembled retrieval kits.
For more insights, visit https://clearviewmarketinsights.com/
About Clearview Market Insights:
Clearview Market Insights is a leading market research and consulting firm providing in-depth industry analysis and strategic recommendations for businesses worldwide.
Media contact:
Bhavani K
Marketing and Sales Head
ClearView Market Insights
Mail: sales@clearviewmarketinsights.com
Phone: +1 917-993-7369
